Predictive value of plasma B-type natriuretic peptide for ischemic stroke: A community-based longitudinal study

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 298-303

  Takahashi, Tomohiro ^a   Nakamura, Motoyuki ^a   Onoda, Toshiyuki ^a   Ohsawa, Masaki ^a   Tanno, Kozo ^a   Itai, Kazuyoshi ^a   Sakata, Kiyomi ^a   Sakuma, Masafumi ^a   Tanaka, Fumitaka ^a   Makita, Shinji ^a   Yoshida, Yuki ^a   Ogawa, Akira ^a   Kawamura, Kazuko ^b   Okayama, Akira ^c  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Iwate Health Service Association   (Japan)

^c FUKUJUJI HOSPITAL   (Japan)

Author keywords

Natriuretic peptide; Population; Risk; Stroke

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

AGED; BIOLOGICAL FACTORS; BRAIN ISCHEMIA; FEMALE; HUMANS; INCIDENCE; JAPAN; KAPLAN-MEIERS ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE; UP-REGULATION;

EID: 70350570558     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.029     Document Type: Article

References (25)

1. Richards A.M., Crozier I.G., Yandle T.G., Espiner E.A., Ikram H., and Nicholls M.G. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 69 (1993) 414-417
2. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
3. Omland T., Aakvaag A., and Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 76 (1996) 232-237
4. Davidson N.C., Naas A.A., Hanson J.K., Kennedy N.S.J., Coutie W.J., and Struthers A.D. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 77 (1996) 828-831
5. Mukoyama M., Nakao K., Saito Y., et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323 (1990) 757-758
6. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
7. Nishigaki K., Tomita M., Kagawa K., et al. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 28 (1996) 1234-1242
8. Sutton T.M., Stewart R.A.H., Gerber I.L., et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 41 (2003) 2280-2287
9. Kohno M., Horio T., Yokokawa K., et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 92 (1992) 29-34
10. Rossi A., Enriquez-Sarano M., Burnett Jr. J.C., Lerman A., Abel M.D., and Seward J.B. Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol 35 (2000) 1256-1262
11. Silvet H., Young-Xu Y., Walleigh D., and Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 92 (2003) 1124-1127
12. Nakamura M., and Hiramori K. Natriuretic peptide measurement as screening test for overt and subclinical heart failure. Int J Cardiol 92 (2003) 9-15
13. Lee S.H., Jung J.H., Choi S.H., et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 70 (2006) 100-104
14. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 43 (1986) 71-84
15. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
16. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., and Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293 (2005) 1609-1616
17. Nakamura M., Onoda T., Itai K., et al. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Int Med 43 (2004) 919-925
18. Ohsawa M, Itai K, Tanno K, et al. Cardiovascular risk factors in the Japanese northeastern rural population. Int J Cardiol 2008. [Epub ahead of print].
19. Omama S., Yoshida Y., Ogawa A., Onoda T., and Okayama A. Differences in circadian variation of cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage by situation at onset. J Neurol Neurosurg Psychiatry 77 (2006) 1345-1349
20. World Health Organization MONICA Project. Event registration data component, MONICA manual version 1.1, document for meeting of MONICA Principal Investigators (1986), World Health Organization, Geneva
21. Kanda H., Kita Y., Okamura T., et al. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?. J Human Hyperten 19 (2005) 165-172
22. McCullough P.A., Duc P., Omland T., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 41 (2003) 571-579
23. Wang T.J., Larson M.G., Levy D., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 109 (2004) 594-600
24. Ohira T., Shahar E., Chambless L.E., Rosamond W.D., Mosley T.H.J., and Folsom A.R. Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities Study. Stroke 37 (2006) 2493-2498
25. Dickstein K., Cohen-Solal A., Filippatos G., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 10 (2008) 933-989